Collective Family Office’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Collective Family Office's BMY Position: Q3 2022 in Review
Collective Family Office sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 6,017 shares — an estimated $463K sold.
Collective Family Office first reported a position in BMY in Q4 2020 and held it in 7 quarters. The position peaked at $463K in Q2 2022. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Collective Family Office reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Collective Family Office sold 6,017 Bristol-Myers Squibb shares in Q3 2022, an estimated $463K.
- Collective Family Office first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 7 quarters.
- Collective Family Office's Bristol-Myers Squibb position peaked at $463K in Q2 2022.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Collective Family Office's 13F filing for Q3 2022, filed 14 Oct 2022.